- Amgen shares new Tavneos analysis in effort to resolve FDA disputeAmgen shared a new analysis with the FDA that the company said supports keeping its controversial rare disease drug Tavneos on the market. The submission, made Thursday, includes an independent r…Endpoints · 54m ago↗ source
- There are already more U.S. measles cases this year than in all of 2025The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of 2026 still to come.STAT · 2h ago↗ source
- STAT+: Up and down the ladder: The latest comings and goingsFrom new hires to departures, promotions, and hires, here are the latest comings and goings in the pharma industry.STAT